Cancer has a biological clock and new drug may keep it from ticking
The findings from scientists at Michelson Center for Convergent Bioscience of the University of Southern California (UniSCal) and Nagoya University’s Institute of Transformative BioMolecules (ITbM) advance a burgeoning area of research: turning the body’s circadian rhythms against cancer (lat. Carcinoma). Scientists know that disrupting sleep and other elements of humans’ circadian rhythm can harm health. The same is true for the circadian clock of the cells themselves. If researchers could disturb the circadian clock of cancer cells, they theorize, they could potentially hurt or kill those cells.